 |
NetWellness is a global, community service providing quality, unbiased health information from our partner university faculty. NetWellness is commercial-free and does not accept advertising.
Thursday, June 20, 2013
|
|
|
NetWellness is a global, community service providing quality, unbiased health information from our partner university faculty. NetWellness is commercial-free and does not accept advertising.
Thursday, June 20, 2013
|
| Home | HealthTopics | Health Centers | Reference Library | Research |
 Join us on Facebook
|
Share on Facebook | Tweet |
|
Asthma |
Atrovent Debate02/21/2001 |
Can you explain to me the debate of using Atrovent for pulmonary diseases? I know it is a generally localized Muscarinic antagonist. Is the debate dealing with the decreased mucous secretion and dilated bronchioles causing more exposure to allergens?
I`m not aware of any debate. Atrovent is a bronchodilator with anticholinergic activity. Several studies have shown excellent action on patients with COPD where it is often considered first line therapy. For asthma it also a bronchodilator but is mainly used as adjunctive therapy.
|
Mitchell C Rashkin, MD Professor of Medicine College of Medicine University of Cincinnati |
|
|
Please note: only your personal physician or other health professional you consult can best advise you on matters of your health based on your medical history, your family medical history, your medication history, and how information from any of these databases may apply to you. Neither University of Cincinnati (NetWellness) nor any party involved in creating, producing or delivering this web site shall be liable for any damages arising out of access to or use of this web site, or any errors or omissions in the content thereof. (More) 
|